Pfizer’s stop-smoking drug Chantix may be one step closer to escaping the FDA’s black box. An agency advisory panel narrowly voted in favor of removing the FDA…

Allergan CEO Brent Saunders drove a stake in the ground last week with his promise to cap drug price increases in a published “social contract” with patients.…

Generic drug prices in Medicare Part D decreased significantly in recent years. So why the worry about price hikes? "Extraordinary" increases on…

FDA scientists are looking askance at Pfizer’s latest attempt to lift a black-box warning from its stop-smoking drug Chantix.

A years-long upswell in orphan drug spending isn't likely to continue, so worries about unsustainable growth in orphan drug costs are unfounded, a new…

Allergan CEO Brent Saunders just made his most dramatic decree yet. “We will limit price increases,” Saunders pledged Tuesday, and when prices do rise, it…

Novo Nordisk’s combination diabetes drug didn’t lap Sanofi’s after all. Two weeks after the FDA put off approval of the French drugmaker’s insulin-plus-GLP-1…

Mylan’s EpiPen tornado is far from its first storm of controversy. The top brass has caught fire for personal use of company aircraft, an unearned degree,…